| Page 1810 | Kisaco Research
 

Dr Pieter-Jan Ceyssens

Unit Head ‘Antibiotics & Resistance’
Sciensano

Dr Pieter-Jan Ceyssens

Unit Head ‘Antibiotics & Resistance’
Sciensano

Dr Pieter-Jan Ceyssens

Unit Head ‘Antibiotics & Resistance’
Sciensano
 

Eric Pelfrene

Office of Anti-infectives and Vaccines, Human Medicines Evaluation Division
EMA

I am employed at the European Medicines Agency (EMA), with responsibilities mainly focused on regulatory guidance pertaining new antibacterial products and medicines for use against WHO target infections, such as malaria.  At EMA we are looking at the lifecycle of each product, through registration and post-authorisation phase, ensuring safe and effective medicines with certified quality to be available for patients throughout the European UnionThe Agency also plays a role in supporting research and innovation in the pharmaceutical sector and pr

Eric Pelfrene

Office of Anti-infectives and Vaccines, Human Medicines Evaluation Division
EMA

Eric Pelfrene

Office of Anti-infectives and Vaccines, Human Medicines Evaluation Division
EMA

I am employed at the European Medicines Agency (EMA), with responsibilities mainly focused on regulatory guidance pertaining new antibacterial products and medicines for use against WHO target infections, such as malaria.  At EMA we are looking at the lifecycle of each product, through registration and post-authorisation phase, ensuring safe and effective medicines with certified quality to be available for patients throughout the European UnionThe Agency also plays a role in supporting research and innovation in the pharmaceutical sector and promotes innovation and development of new medicines by European micro- small- and medium-sized-enterprises.

 

Dr Sofia Corte-Real

Scientific Consultant
Technophage

Dr Sofia Corte-Real

Scientific Consultant
Technophage

Dr Sofia Corte-Real

Scientific Consultant
Technophage
 

Dr Burak Alver

Dr Burak Alver

Dr Burak Alver

 

Dr Lihua Yu

Dr Lihua Yu

Dr Lihua Yu

 

Rob Fink

Founder & CEO
Big Drop Brewing

Rob Fink is CEO of Big Drop, a company he founded with zero brewing experience less than three years ago. And there wasn’t even anyone he could emulate… Rob was the first ever brewer to focus exclusively on Alcohol Free beer and the first to apply left-field fermenting techniques that meant no alcohol needed to be artificially extracted from the end product after brewing. Big Drop’s range of 0.5% ABV craft beers are available in supermarkets (Tesco, Ocado, Morrisons) with on-trade listings including: All Bar One, The Ivy Group, Barworks and Draft House.

Rob Fink

Founder & CEO
Big Drop Brewing

Rob Fink

Founder & CEO
Big Drop Brewing

Rob Fink is CEO of Big Drop, a company he founded with zero brewing experience less than three years ago. And there wasn’t even anyone he could emulate… Rob was the first ever brewer to focus exclusively on Alcohol Free beer and the first to apply left-field fermenting techniques that meant no alcohol needed to be artificially extracted from the end product after brewing. Big Drop’s range of 0.5% ABV craft beers are available in supermarkets (Tesco, Ocado, Morrisons) with on-trade listings including: All Bar One, The Ivy Group, Barworks and Draft House. It has won numerous awards including No/Lo Champion at the 2019 International Brewing Awards and - the ‘Holy Grail’ of any non-alcoholic drink - winning against full-strength competitors (eg at the World Beer Awards and King of Craft at the Casual Dining show). Now with exports shortly to account for half of sales, Big Drop is also becoming a big name overseas too.

 

Dr. Nur A Hasan

CSO
CosmosID

Dr. Nur A Hasan is a molecular microbiologist with experiences in microbial genomics, metagenomics, and molecular ecology. Dr. Hasan is the Chief Scientific Officer at CosmosID Inc. and an adjunct faculty at the Center for Bioinformatics and Computational Biology, University of Maryland, College Park, MD. Dr. Hasan received his Bachelor and Masters in Microbiology, M.B.A in Marketing and Ph.D. in Molecular Biology. He has authored over 75 peer-reviewed articles and over 70 conference proceedings. Currently, Dr.

Dr. Nur A Hasan

CSO
CosmosID

Dr. Nur A Hasan

CSO
CosmosID

Dr. Nur A Hasan is a molecular microbiologist with experiences in microbial genomics, metagenomics, and molecular ecology. Dr. Hasan is the Chief Scientific Officer at CosmosID Inc. and an adjunct faculty at the Center for Bioinformatics and Computational Biology, University of Maryland, College Park, MD. Dr. Hasan received his Bachelor and Masters in Microbiology, M.B.A in Marketing and Ph.D. in Molecular Biology. He has authored over 75 peer-reviewed articles and over 70 conference proceedings. Currently, Dr. Hasan is leading an effort in developing the world’s largest curated genome databases and ultra rapid bioinformatics platform for pathogen detection and cross-disciplinary microbiome research.